The FDA approved a new one-pill formulation of the emergency contraceptive Plan B in July.
The Food and Drug Administration (FDA) approved a new one-pill formulation of the emergency contraceptive (EC) Plan B in July. Called Plan B One-Step, the product is available behind the counter without a prescription to women 17 or older. The FDA also recently approved Next Choice, a generic version of the original two-pill Plan B formulation, which is obtainable by prescription to those 17 or younger.
The American College of Obstetricians and Gynecologists (ACOG) praised the recent FDA actions, saying the new formulation "will simplify this important pregnancy prevention treatment" (ACOG press release, 7/15/09). However, ACOG also reiterated its "long-held position that there is no valid scientific or medical reason to impose an age restriction on the availability of EC because it is safe and effective for adolescents and women of all ages." It urged the FDA "to withdraw the age restriction altogether and eliminate the behind-the-counter status for EC."
Adverse maternal outcomes after uterine conservation in placenta accreta spectrum
May 9th 2024A review of 5 studies reveals a significant 1 in 4 incidence of adverse maternal outcomes following uterine conservation in patients with placenta accreta spectrum, underlining the importance of expert multidisciplinary care.
Read More
Barriers in seeking pelvic floor disorder treatment among ethnic minorities
May 8th 2024A recent shed light on how ethnic minority groups perceive pelvic floor disorders, highlighting barriers to treatment seeking and the importance of raising awareness about available treatment options.
Read More
Variations found in testosterone therapy for women with HSDD
May 7th 2024Dive into the intricate landscape of testosterone therapy prescriptions among women with hypoactive sexual desire disorder, revealing diverse patterns in duration, administration routes, and estrogen co-administration.
Read More